Literature DB >> 7693902

Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment.

M C Fisher1, J J LiPuma, S E Dasen, G C Caputo, J E Mortensen, K L McGowan, T L Stull.   

Abstract

Ribotyping, an analysis of bacterial strain identity based on chromosomal restriction fragment length polymorphisms, was performed on 68 isolates of Pseudomonas cepacia recovered from patients receiving care at the two children's hospitals in Philadelphia and from environmental samples. Twenty different ribotypes were identified. Ribotype R3 predominated among isolates from all three sources. These findings are consistent with the acquisition of P. cepacia from the environment or by person-to-person transmission.

Entities:  

Mesh:

Year:  1993        PMID: 7693902     DOI: 10.1016/s0022-3476(05)80851-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

Authors:  S L Butler; C J Doherty; J E Hughes; J W Nelson; J R Govan
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

2.  Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center.

Authors:  H Vu-Thien; D Moissenet; M Valcin; C Dulot; G Tournier; A Garbarg-Chenon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

3.  Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients.

Authors:  H C Ryley; B Ojeniyi; N Høiby; J Weeks
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

Review 4.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.

Authors:  C Segonds; E Bingen; G Couetdic; S Mathy; N Brahimi; N Marty; P Plesiat; Y Michel-Briand; G Chabanon
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

Review 6.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

7.  Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.

Authors:  M L Whiteford; J D Wilkinson; J H McColl; F M Conlon; J R Michie; T J Evans; J Y Paton
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

8.  Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia.

Authors:  R Goldstein; L Sun; R Z Jiang; U Sajjan; J F Forstner; C Campanelli
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

Review 9.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.